Also trades as: VVY.AS (AMS) · $vol 0M
0R3M.L LSE
Vivoryon Therapeutics N.V.
1W: +0.0%
1M: -2.7%
3M: -7.6%
YTD: -23.8%
1Y: -24.3%
3Y: -90.9%
€1.10 ($1.24)
+0.02 (+1.84%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
#9
of 12
Biotechnology
Technical Signal Map
2 Bullish
1 Neutral
10 Bearish
0R3M.L
$30M
Vivoryon Therapeutics N.V.
BEARISH
-100
BNN.DE
$60M
BRAIN Biotech AG
BULLISH
+66
V3V.DE
$110M
FamiCord AG
BULLISH
+59
AFMDQ
—
Affimed N.V.
NEUTRAL
+6
ALTME.PA
$10M
TME Pharma N.V.
LEAN BEAR
-13
BNTX
$24B
BioNTech SE
BEARISH
-59
IMTX
$1.1B
Immatics N.V.
BEARISH
-66
VVY.AS
$30M
Vivoryon Therapeutics N.V.
BEARISH
-66
FYB.DE
$350M
Formycon AG
BEARISH
-75
HPHA.DE
$110M
Heidelberg Pharma AG
BEARISH
-75
IFRX
$250M
InflaRx N.V.
BEARISH
-84
VRXA
$170M
Veraxa Biotech Holding AG
BEARISH
-91
VRXAW
—
Veraxa Biotech AG
BEARISH
-91
Peer Comparison
| Symbol | Mkt Cap | P/E | ROE % | ROIC % | Net Mgn % | Rev Grw % | Piotroski | Signal | 1Y Ret % |
|---|---|---|---|---|---|---|---|---|---|
| 0R3M.L Vivoryon Therapeutics N.V. | $30M | -4.8 | -247.7 | 1935.3 | — | 100.0 | 3 | BEARISH | -24.3 |
| BNN.DE BRAIN Biotech AG | $60M | -4.4 | 3079.8 | 96.5 | -31.7 | 11.5 | 3 | BULLISH | 31.4 |
| V3V.DE FamiCord AG | $110M | -7.1 | -84.3 | -13.6 | -5.1 | 0.1 | 5 | BULLISH | -57.2 |
| AFMDQ Affimed N.V. | — | — | — | — | — | — | — | NEUTRAL | — |
| ALTME.PA TME Pharma N.V. | $10M | -3.0 | 961.8 | 688.6 | 4381.5 | 11.8 | 3 | LEAN BEAR | 1.0 |
| BNTX BioNTech SE | $24B | -12.7 | -9.3 | -18.0 | -777.3 | -8.2 | 2 | BEARISH | -5.2 |
| IMTX Immatics N.V. | $1.1B | -4.3 | -47.8 | -858.3 | -683.4 | -68.0 | 2 | BEARISH | -15.7 |
| VVY.AS Vivoryon Therapeutics N.V. | $30M | -4.8 | -247.7 | 1935.3 | — | 100.0 | 3 | BEARISH | -34.9 |
| FYB.DE Formycon AG | $350M | -12.9 | -40.5 | -12.0 | -56.8 | -12.7 | 2 | BEARISH | -24.1 |
| HPHA.DE Heidelberg Pharma AG | $110M | -3.4 | -1539.9 | 68.8 | 19.9 | 78.0 | 4 | BEARISH | -48.4 |
| IFRX InflaRx N.V. | $250M | -3.2 | -38.5 | 251.5 | — | -106.2 | 4 | BEARISH | 26.5 |
| VRXA Veraxa Biotech Holding AG | $170M | — | — | — | — | — | — | BEARISH | — |
| VRXAW Veraxa Biotech AG | — | — | — | — | — | — | — | BEARISH | — |
| 0R3M.L Vivoryon Therapeutics N.V. | $30M | -4.8 | -247.7 | 1935.3 | — | 100.0 | 3 | BEARISH | -24.3 |
| BNN.DE BRAIN Biotech AG | $60M | -4.4 | 3079.8 | 96.5 | -31.7 | 11.5 | 3 | BULLISH | 31.4 |
| V3V.DE FamiCord AG | $110M | -7.1 | -84.3 | -13.6 | -5.1 | 0.1 | 5 | BULLISH | -57.2 |
| AFMDQ Affimed N.V. | — | — | — | — | — | — | — | NEUTRAL | — |
| ALTME.PA TME Pharma N.V. | $10M | -3.0 | 961.8 | 688.6 | 4381.5 | 11.8 | 3 | LEAN BEAR | 1.0 |
| BNTX BioNTech SE | $24B | -12.7 | -9.3 | -18.0 | -777.3 | -8.2 | 2 | BEARISH | -5.2 |
| IMTX Immatics N.V. | $1.1B | -4.3 | -47.8 | -858.3 | -683.4 | -68.0 | 2 | BEARISH | -15.7 |
| VVY.AS Vivoryon Therapeutics N.V. | $30M | -4.8 | -247.7 | 1935.3 | — | 100.0 | 3 | BEARISH | -34.9 |
| FYB.DE Formycon AG | $350M | -12.9 | -40.5 | -12.0 | -56.8 | -12.7 | 2 | BEARISH | -24.1 |
| HPHA.DE Heidelberg Pharma AG | $110M | -3.4 | -1539.9 | 68.8 | 19.9 | 78.0 | 4 | BEARISH | -48.4 |
| IFRX InflaRx N.V. | $250M | -3.2 | -38.5 | 251.5 | — | -106.2 | 4 | BEARISH | 26.5 |
| VRXA Veraxa Biotech Holding AG | $170M | — | — | — | — | — | — | BEARISH | — |
| VRXAW Veraxa Biotech AG | — | — | — | — | — | — | — | BEARISH | — |
Profile Radar
Valuation vs Profitability
Performance Comparison
Industry Market Share
0R3M.L vs Benchmarks
ROIC
Revenue Growth
P/E Ratio
ROE
Piotroski F